Loading...

Discover something new with just one click.

Shuffle Most Popular Featured

Press Release

FDA Grants Genentech’s Avastin Priority Review For Recurrent Platinum-resistant Ovarian Cancer

Genentech Agrees to Acquire Seragon to Strengthen Breast Cancer Pipeline

Read about Genentech’s planned acquisition of Seragon.

FDA Approval

Medicine for people with chronic idiopathic urticaria (CIU), a form of chronic hives.

Patient Access

Genentech is committed to ensuring price is not a barrier to access for patients. Learn about our programs.

Announcing Sunshine Track

Physicians can now use our secure online portal to review Sunshine-reportable payments before they are reported to the government.

Job Search

Search for jobs. Learn more about what is currently available. And then apply for the position at Genentech that’s right for you.

Clinical Trial Data Sharing

As part of our commitment to sharing data from our clinical trials, researchers may now request access to analyzable patient-level data. Learn more.

Exposing Innovation

We’re working together to shape the future of biotech. Take a look inside Genentech.

Our Pipeline

Our pipeline includes new molecular entities that address serious unmet medical needs.

Collaborating With Managed Care

Insights on trends, events, and therapeutic advances. Learn more at Genentech-Forum.com.

Genentech named FORTUNE Best Company

We've been named to FORTUNE's "100 Best Companies to Work For" list for the 16th year in a row.

Building Towards a Sustainable Future

In an effort to increase sustainability practices on our SSF campus, we've joined the US Green Buildings Challenge.

Silkscreened Stories

At Genentech, our t-shirts represent our stories - about our people, our community, and ultimately about the impact of biotechnology on medicine.

Our Medicines

Find links to info and resources on each of our medicines, including prescribing information, material data safety sheets, medication guides, and healthcare provider letters.

Pioneering Partnerships

Partnering is a relatively new phenomenon for biopharmaceutical companies, but collaboration has been part of Genentech’s DNA from the beginning.